{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "bf69dc18",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/macharya/dev/medkg-eval/medkg/lib/python3.13/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Imports and setup complete.\n"
     ]
    }
   ],
   "source": [
    "# debug_rag_pipeline.ipynb\n",
    "\n",
    "# Cell 1: Imports and Initial Setup\n",
    "# ==================================\n",
    "# This cell contains all the necessary imports and loads the environment variables.\n",
    "\n",
    "import logging\n",
    "import json\n",
    "import re\n",
    "import time\n",
    "import os\n",
    "import ast\n",
    "import pandas as pd\n",
    "from dotenv import load_dotenv\n",
    "from json_repair import repair_json\n",
    "import faiss\n",
    "import numpy as np\n",
    "from openai import OpenAI\n",
    "from sentence_transformers import SentenceTransformer, CrossEncoder\n",
    "from nebula3.gclient.net import ConnectionPool\n",
    "from nebula3.Config import Config\n",
    "from llama_index.llms.ollama import Ollama\n",
    "import torch\n",
    "from transformers import BertTokenizer, BertModel, AutoTokenizer, AutoModel\n",
    "from bertviz import head_view, model_view\n",
    "import warnings\n",
    "\n",
    "# Configure logging to be clear in the notebook\n",
    "logging.basicConfig(level=logging.INFO, format='%(asctime)s - %(levelname)s - %(message)s', force=True)\n",
    "\n",
    "# Load environment variables from the .env file in the parent directory\n",
    "load_dotenv(dotenv_path='../.env')\n",
    "\n",
    "print(\"Imports and setup complete.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "94843b90",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All helper functions defined.\n"
     ]
    }
   ],
   "source": [
    "# Cell 2: Define All Helper Functions\n",
    "# =====================================\n",
    "# This cell contains all the stateless helper functions from your RAG pipeline.\n",
    "# You can run this once and then focus on the main logic cell.\n",
    "\n",
    "# --- ROBUST FILE PATHS ---\n",
    "_CURR_DIR = os.getcwd() # Get current working directory of the notebook\n",
    "MODEL_NAME = \"pritamdeka/S-PubMedBert-MS-MARCO\"\n",
    "INDEX_FILE = os.path.join(_CURR_DIR, \"../graph_rag/faiss_index.bin\")\n",
    "TEXTS_FILE = os.path.join(_CURR_DIR, \"../graph_rag/semantic_nodes.json\")\n",
    "\n",
    "def connect_nebula():\n",
    "    try:\n",
    "        config = Config()\n",
    "        config.max_connection_pool_size = 10\n",
    "        connection_pool = ConnectionPool()\n",
    "        connection_pool.init([(\"127.0.0.1\", 9669)], config)\n",
    "        client = connection_pool.get_session(\"root\", \"nebula\")\n",
    "        client.execute(\"USE petagraph;\")\n",
    "        logging.info(\"Successfully connected to NebulaGraph.\")\n",
    "        return client, connection_pool\n",
    "    except Exception as e:\n",
    "        logging.error(f\"Failed to connect to NebulaGraph: {e}\")\n",
    "        return None, None\n",
    "\n",
    "def load_faiss_index():\n",
    "    try:\n",
    "        index = faiss.read_index(INDEX_FILE)\n",
    "        with open(TEXTS_FILE, \"r\") as f: texts = json.load(f)\n",
    "        logging.info(f\"FAISS index loaded successfully from: {INDEX_FILE}\")\n",
    "        return index, texts\n",
    "    except Exception as e:\n",
    "        logging.error(f\"Could not load FAISS index from '{INDEX_FILE}'. Error: {e}\")\n",
    "        return None, None\n",
    "\n",
    "def load_prompt_assets(task_name, prompt_id, max_shots, library_dir=\"prompt_library\"):\n",
    "    assets = {\"prompt\": \"\", \"output_format\": \"\", \"shots\": []}\n",
    "    task_dir = os.path.join(library_dir, task_name)\n",
    "    prompts_path = os.path.join(task_dir, \"prompts.json\")\n",
    "    if os.path.exists(prompts_path):\n",
    "        with open(prompts_path, 'r') as f:\n",
    "            prompts = json.load(f).get(\"prompts\", [])\n",
    "            selected = next((p for p in prompts if p.get(\"id\") == prompt_id), None)\n",
    "            if selected: assets.update(selected)\n",
    "    shots_path = os.path.join(task_dir, \"shots.json\")\n",
    "    if os.path.exists(shots_path):\n",
    "        with open(shots_path, 'r') as f:\n",
    "            shots_list = json.load(f).get(\"shots\", [])\n",
    "            loaded_shots = shots_list[0] if shots_list and isinstance(shots_list[0], list) else shots_list\n",
    "            assets[\"shots\"] = loaded_shots[:max_shots]\n",
    "    logging.info(f\"Loaded {len(assets['shots'])} shots for '{task_name}' (max_shots: {max_shots}).\")\n",
    "    return assets\n",
    "\n",
    "# def retrieve_semantic_seeds(query, model, index, texts, top_k=50):\n",
    "#     query_vec = model.encode([query], convert_to_numpy=True)\n",
    "#     _, indices = index.search(query_vec, top_k)\n",
    "#     return [texts[i][\"sui\"] for i in indices[0]]\n",
    "\n",
    "def retrieve_semantic_nodes(query, model, index, texts, top_k=50, top_m=10):\n",
    "    \"\"\"\n",
    "    MODIFIED: This function now retrieves both the top_k SUIs for graph traversal\n",
    "    and the top_m full semantic texts for direct use.\n",
    "    \"\"\"\n",
    "    query_vec = model.encode([query], convert_to_numpy=True)\n",
    "    _, indices = index.search(query_vec, top_k)\n",
    "    \n",
    "    top_indices = indices[0]\n",
    "    \n",
    "    # Get the SUIs for the top_k results (for potential graph traversal)\n",
    "    top_k_suis = [texts[i][\"sui\"] for i in top_indices]\n",
    "    \n",
    "    # --- YOUR NEW FEATURE ---\n",
    "    # Get the full text content for the top_m results directly.\n",
    "    # We use [:top_m] to select the m most similar results from the top_k.\n",
    "    top_m_texts = [texts[i][\"name\"] for i in top_indices[:top_m]]\n",
    "    \n",
    "    logging.info(f\"Retrieved {len(top_k_suis)} SUIs and the top {len(top_m_texts)} semantic texts.\")\n",
    "    return top_k_suis, top_m_texts\n",
    "\n",
    "def get_definitions_from_graph(client, suis):\n",
    "    if not suis: return []\n",
    "    try:\n",
    "        suis_str = \", \".join(f'\"{sui}\"' for sui in suis)\n",
    "        resp_cuis = client.execute(f'GO FROM {suis_str} OVER STY REVERSELY YIELD DISTINCT src(edge) AS cui')\n",
    "        if resp_cuis.is_empty(): return []\n",
    "        cuis = [r.values[0].get_sVal().decode(\"utf-8\") for r in resp_cuis.rows()]\n",
    "        cuis_str = \", \".join(f'\"{cui}\"' for cui in cuis)\n",
    "        resp_defs = client.execute(f'GO FROM {cuis_str} OVER DEF YIELD DISTINCT dst(edge) AS def_id')\n",
    "        if resp_defs.is_empty(): return []\n",
    "        def_ids = [r.values[0].get_sVal().decode(\"utf-8\") for r in resp_defs.rows()]\n",
    "        def_ids_str = \", \".join(f'\"{d}\"' for d in def_ids)\n",
    "        resp_final = client.execute(f'FETCH PROP ON Definition {def_ids_str} YIELD Definition.DEF')\n",
    "        if resp_final.is_empty(): return []\n",
    "        return [r.values[0].get_sVal().decode(\"utf-8\") for r in resp_final.rows()]\n",
    "    except Exception as e:\n",
    "        logging.error(f\"An error during graph traversal: {e}\")\n",
    "        return []\n",
    "\n",
    "def rerank_definitions(question, definitions, top_k=15):\n",
    "    if not definitions: return []\n",
    "    cross_encoder = CrossEncoder('pritamdeka/S-PubMedBert-MS-MARCO')\n",
    "    # The rest of the function works exactly the same, but the results will be much better.\n",
    "    scores = cross_encoder.predict([[question, d] for d in definitions])\n",
    "    scored_definitions = sorted(zip(scores, definitions), key=lambda x: x[0], reverse=True)\n",
    "    top_definitions = [d for _, d in scored_definitions[:top_k]]\n",
    "    logging.info(f\"Re-ranked {len(definitions)} definitions and selected the top {len(top_definitions)}.\")\n",
    "    return top_definitions\n",
    "\n",
    "def format_shots(shots):\n",
    "    if not shots: return \"\"\n",
    "    examples = []\n",
    "    for shot in shots:\n",
    "        inp = shot.get(\"input\", {})\n",
    "        out = shot.get(\"Output\", {})\n",
    "        opts = \"\\\\n\".join([f\"{k}: {v}\" for k, v in inp.get(\"Options\", {}).items()])\n",
    "        example = (f\"---\\nExample Question: {inp.get('Question', '')}\\nExample Options:\\n{opts}\\n\"\n",
    "                   f\"Example Correct Answer:\\n```json\\n{json.dumps(out, indent=2)}\\n```\\n---\")\n",
    "        examples.append(example)\n",
    "    return \"\\\\n\\\\n\".join(examples)\n",
    "\n",
    "def generate_llm_response(llm_client, model_name, question, options, definitions, prompt_assets, consistency_result=\"\", no_rag=False):\n",
    "    \"\"\"\n",
    "    MODIFIED: This function now dynamically builds the prompt based on whether\n",
    "    RAG is enabled, omitting the Context and Guidance sections in no-RAG mode.\n",
    "    \"\"\"\n",
    "    main_prompt_instruction = prompt_assets.get(\"prompt\", \"\")\n",
    "    few_shot_str = format_shots(prompt_assets.get(\"shots\", []))\n",
    "    options_str = \"\\\\n\".join([f\"{k}: {v}\" for k, v in options.items()])\n",
    "    output_format_instruction = (\n",
    "        \"You MUST provide your response as a single, valid JSON object with the following keys:\\n\"\n",
    "        \"1. `cop_index`: The integer index of the correct option.\\n\"\n",
    "        \"2. `answer`: The full string value of the correct option.\\n\"\n",
    "        \"3. `why_correct`: A detailed explanation of only the correct answer. This explanation MUST follow a specific three-part structure:\\n\"\n",
    "        \"   - First, briefly state the key concepts in the question.\\n\"\n",
    "        \"   - Second, quote all the exact sentences from the Context that directly support your answer.\\n\"\n",
    "        \"   - Finally, provide a concluding sentence that links the evidence to the chosen answer.\\n\"\n",
    "        \"4. `why_others_incorrect`: A brief explanation for why each of the other options is wrong.\"\n",
    "    )\n",
    "    \n",
    "    # --- DYNAMIC PROMPT COMPONENT LOGIC ---\n",
    "    context_block = \"\"\n",
    "    consistency_guidance = \"\"\n",
    "    if not no_rag:\n",
    "        # Only add context and guidance if RAG is enabled.\n",
    "        context_str = \" \".join(definitions) if definitions else \"No relevant biomedical context found.\"\n",
    "        context_block = f\"Context: {context_str}\\n\\n\"\n",
    "        if consistency_result in [\"CONTRADICTED\", \"NEUTRAL\"]:\n",
    "            consistency_guidance = (\n",
    "                f\"\\n--- CRITICAL GUIDANCE ---\\nA fact-check determined the context is '{consistency_result}' to the question's premise. This strongly indicates the question is flawed or unanswerable. \"\n",
    "                f\"Your primary task is to explain WHY the question is flawed. Set 'cop_index' to the 'None of the above' option if it exists, otherwise set it to -1.\\n--- END GUIDANCE ---\\n\"\n",
    "            )\n",
    "\n",
    "    # Assemble the final prompt from the dynamic components\n",
    "    base_prompt = (\n",
    "        f\"{main_prompt_instruction}\\n\"\n",
    "        f\"{consistency_guidance}\" # Will be empty in no-RAG mode\n",
    "        f\"Examples:\\n{few_shot_str}\\n\\n\"\n",
    "        f\"--- CURRENT TASK ---\\n\"\n",
    "        f\"{context_block}\" # Will be empty in no-RAG mode\n",
    "        f\"Question: {question}\\nOptions:\\n{options_str}\\n\\n\"\n",
    "        f\"Provide your answer. {output_format_instruction}\"\n",
    "    )\n",
    "    for attempt in range(2):\n",
    "        prompt = base_prompt + (\"\\n\\nYour previous response was invalid. Please provide ONLY the JSON object.\" if attempt > 0 else \"\")\n",
    "        try:\n",
    "            response = llm_client.chat.completions.create(model=model_name, messages=[{\"role\": \"user\", \"content\": prompt}], temperature=0.0, response_format={\"type\": \"json_object\"})\n",
    "            raw_text = response.choices[0].message.content\n",
    "            # response = llm_client.complete(prompt)\n",
    "            # raw_text = response.text\n",
    "            repaired_json_str = repair_json(raw_text)\n",
    "            \n",
    "            # 2. Parse the now-guaranteed-to-be-valid JSON string.\n",
    "            parsed_json = json.loads(repaired_json_str)\n",
    "\n",
    "            if 'cop_index' not in parsed_json:\n",
    "                raise ValueError(\"Output JSON is missing the required 'cop_index' key.\")\n",
    "            \n",
    "            return parsed_json, definitions\n",
    "        except Exception as e:\n",
    "            logging.warning(f\"Attempt {attempt + 1} failed: {e}. Raw response: '{locals().get('raw_text', 'N/A')}'\")\n",
    "            time.sleep(1)\n",
    "    logging.error(f\"Failed to get valid LLM response after multiple attempts.\")\n",
    "    return None, definitions\n",
    "\n",
    "print(\"All helper functions defined.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "dd22bc69",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-05 05:05:52,470 - INFO - Use pytorch device_name: cuda:0\n",
      "2025-08-05 05:05:52,472 - INFO - Load pretrained SentenceTransformer: pritamdeka/S-PubMedBert-MS-MARCO\n",
      "2025-08-05 05:06:44,066 - INFO - FAISS index loaded successfully from: /home/macharya/dev/medkg-eval/../graph_rag/faiss_index.bin\n",
      "2025-08-05 05:06:44,083 - INFO - Get connection to ('127.0.0.1', 9669)\n",
      "2025-08-05 05:06:44,094 - INFO - Successfully connected to NebulaGraph.\n"
     ]
    }
   ],
   "source": [
    "# Cell 3: Load Heavy, Shared Resources\n",
    "# ======================================\n",
    "# This cell loads the FAISS index, Sentence Transformer, and connects to Nebula.\n",
    "# This is a slow cell, so you only run it once per session.\n",
    "\n",
    "st_model = SentenceTransformer(MODEL_NAME)\n",
    "faiss_index, faiss_texts = load_faiss_index()\n",
    "nebula_client, nebula_pool = connect_nebula()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "4b5063f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All heavy resources loaded and ready.\n"
     ]
    }
   ],
   "source": [
    "# Initialize the OpenAI client for the LLM\n",
    "llm_client = OpenAI(base_url=os.getenv(\"OPENAI_BASE_URL\"), api_key=os.getenv(\"API_KEY\"))\n",
    "#llm_client= Ollama(model=\"llama3:8b\", request_timeout=300)\n",
    "\n",
    "#response = llm.complete(prompt)\n",
    "#print(response)\n",
    "\n",
    "print(\"All heavy resources loaded and ready.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "75a78dec",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- DEBUGGING ID: 197feaf8-e848-4d28-9c4e-5b43b8e4ded7 ---\n",
      "Question: A 7-year-old girl is brought to the physician by her mother because of a 6-month history of worsening fatigue and frequent upper respiratory tract infections. She is at the 2nd percentile for height and 10th percentile for weight. Physical examination shows pallor, diffuse hyperpigmented macules, absence of the radial bones, and hypoplastic thumbs. Her hemoglobin concentration of 8.7 g/dL, leukocyte count is 2,500/mm3, and platelet count is 30,000/mm3. This patient's condition is most likely caused by a defect in a gene encoding a protein that is normally involved in which of the following processes?\n",
      "Options: {'0': 'Hydrolysis of glucocerebroside', '1': 'DNA interstrand crosslink repair', '2': 'Maturation of erythroid progenitor cells', '3': 'Ras signal transduction pathway', 'correct answer': 'Maturation of erythroid progenitor cells'}\n",
      "Correct Index: 1 ('DNA interstrand crosslink repair')\n",
      "--------------------------------------------------\n",
      "\n",
      "--- STAGE 1: Semantic Retrieval (Top 20) ---\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Batches:   0%|          | 0/1 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/macharya/dev/medkg-eval/medkg/lib/python3.13/site-packages/torch/nn/modules/module.py:1762: FutureWarning: `encoder_attention_mask` is deprecated and will be removed in version 4.55.0 for `BertSdpaSelfAttention.forward`.\n",
      "  return forward_call(*args, **kwargs)\n",
      "Batches: 100%|██████████| 1/1 [00:00<00:00,  1.17it/s]\n",
      "2025-08-04 04:09:30,706 - INFO - Retrieved 30000 SUIs and the top 30 semantic texts.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 30000 semantic seeds (SUIs).\n",
      "--------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Cell 4: The Interactive Debugging Cell\n",
    "# =======================================\n",
    "# THIS IS THE MAIN CELL YOU WILL USE FOR DEBUGGING.\n",
    "# 1. Set the parameters for the question you want to debug.\n",
    "# 2. Run this cell to see the output of each stage.\n",
    "# 3. Analyze the output and tune the parameters (e.g., top_k values).\n",
    "# 4. Re-run this cell to see the effect of your changes instantly.\n",
    "\n",
    "# --- 1. SET YOUR DEBUGGING PARAMETERS HERE ---\n",
    "TASK_NAME = 'reasoning_fct'\n",
    "PROMPT_ID = 'v0'\n",
    "MAX_SHOTS = 3\n",
    "MODEL_NAME_TO_DEBUG = 'deepseek-r1:14b'\n",
    "\n",
    "# ID of the specific question you want to analyze (find this in your CSV)\n",
    "QUESTION_ID_TO_DEBUG = \"140d832a-b8ae-4791-aada-6fd62f313adb\"  #\"839de867-3100-4283-a219-ec349eee415f\"  \n",
    "\n",
    "# You can also tune these parameters for experiments\n",
    "RETRIEVAL_TOP_K = 20\n",
    "RERANK_TOP_K = 15\n",
    "\n",
    "# --- 2. LOAD THE SPECIFIC QUESTION DATA ---\n",
    "data_file = f\"data/{TASK_NAME}.csv\"\n",
    "df = pd.read_csv(data_file)\n",
    "question_row = df[df['id'] == QUESTION_ID_TO_DEBUG].iloc[0]\n",
    "\n",
    "question = question_row['question']\n",
    "options = ast.literal_eval(question_row['options'])\n",
    "correct_index = question_row['correct_index']\n",
    "correct_answer_text = question_row['correct_answer']\n",
    "\n",
    "print(f\"--- DEBUGGING ID: {QUESTION_ID_TO_DEBUG} ---\")\n",
    "print(f\"Question: {question}\")\n",
    "print(f\"Options: {options}\")\n",
    "print(f\"Correct Index: {correct_index} ('{correct_answer_text}')\")\n",
    "print(\"--------------------------------------------------\\n\")\n",
    "\n",
    "# --- 3. RUN THE RAG PIPELINE STEP-BY-STEP ---\n",
    "\n",
    "# --- STAGE 1: SEMANTIC RETRIEVAL ---\n",
    "print(f\"--- STAGE 1: Semantic Retrieval (Top {RETRIEVAL_TOP_K}) ---\")\n",
    "query = question + \" \" + \" \".join(options.values())\n",
    "# suis = retrieve_semantic_seeds(query, st_model, faiss_index, faiss_texts, top_k=RETRIEVAL_TOP_K)\n",
    "suis, top_semantic_texts = retrieve_semantic_nodes(query, st_model, faiss_index, faiss_texts, top_k=30000, top_m=30)\n",
    "print(f\"Found {len(suis)} semantic seeds (SUIs).\")\n",
    "print(\"--------------------------------------------------\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "6940875f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- STAGE 2: Knowledge Graph Traversal ---\n",
      "Retrieved 717 definitions from the graph.\n",
      "  Initial Def [0]: Severe combined immunodeficiency (SCID) T-B+ due to JAK3 deficiency is a form of SCID characterized by severe and recurr...\n",
      "  Initial Def [1]: A decreased concentration of 5-methyltetrahydrofolate in the blood. []...\n",
      "  Initial Def [2]: A semi-quantitative microscopic finding indicating that 5 percent or more of the nucleated cells in a bone marrow sample...\n",
      "  Initial Def [3]: A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by developmental delay with mild intellec...\n",
      "  Initial Def [4]: Elevated bilirubin levels in the blood of a newborn infant. It is a normal response due to the limited ability to excret...\n",
      "--------------------------------------------------\n",
      "\n",
      "--- STAGE 3: Re-ranking (Top 15) ---\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of BertForSequenceClassification were not initialized from the model checkpoint at pritamdeka/S-PubMedBert-MS-MARCO and are newly initialized: ['classifier.bias', 'classifier.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n",
      "2025-08-04 04:45:44,547 - INFO - Use pytorch device: cuda:0\n",
      "Batches:   0%|          | 0/23 [00:00<?, ?it/s]/home/macharya/dev/medkg-eval/medkg/lib/python3.13/site-packages/torch/nn/modules/module.py:1762: FutureWarning: `encoder_attention_mask` is deprecated and will be removed in version 4.55.0 for `BertSdpaSelfAttention.forward`.\n",
      "  return forward_call(*args, **kwargs)\n",
      "Batches: 100%|██████████| 23/23 [00:01<00:00, 14.90it/s]\n",
      "2025-08-04 04:45:46,345 - INFO - Re-ranked 717 definitions and selected the top 15.\n",
      "2025-08-04 04:45:46,347 - INFO - Loaded 3 shots for 'reasoning_fct' (max_shots: 3).\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Selected the top 45 most relevant definitions.\n",
      "  Final Ctx [0]: HEMOGLOBIN LEVEL 11 G/DL-12.9 G/DL...\n",
      "  Final Ctx [1]: Hemoglobin A2+C+E+O/Hemoglobin.total &#x7C; Blood &#x7C; Hematology and Cell counts...\n",
      "  Final Ctx [2]: G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis...\n",
      "  Final Ctx [3]: Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)...\n",
      "  Final Ctx [4]: Mental retardation, unusual facies, short stature, hyperextensibility of the joints, clinodactyly of the fifth fingers, ...\n",
      "  Final Ctx [5]: 8-75 ENDOCRINE, METABOLIC AND HEMATOLOGIC DISORDERS SPECIFIC TO THE FETUS OR NEWBORN...\n",
      "  Final Ctx [6]: An association of hypoplastic corpus callosum, mental retardation, adducted thumbs, spastic paraparesis, and hydrocephal...\n",
      "  Final Ctx [7]: Review maternal and infant history for risk factors for hyperbilirubinemia (e.g., Rh or ABO incompatibility, polycythemi...\n",
      "  Final Ctx [8]: A sporadic syndrome of brachydactyly, thin habitus with narrow shoulders, mesomelic shortness of the arms, long lower fa...\n",
      "  Final Ctx [9]: I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D:Find:7D:^Patient:Ord:FACIT...\n",
      "  Final Ctx [10]: G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)...\n",
      "  Final Ctx [11]: Teach patient to monitor self for signs and symptoms that indicate need for medical treatment (e.g., fever, bleeding, re...\n",
      "  Final Ctx [12]: Leukomelanoderma, Infantilism, Mental Retardation, Hypodontia, Hypotrichosis...\n",
      "  Final Ctx [13]: Síndrome caracterizado por anemia hemolítica no esferocítica debida a deficiencia de trifosfatasa de adenosina (ATPasa)....\n",
      "  Final Ctx [14]: CEREBELLAR HYPOPLASIA, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, CONGENITAL MICROCEPHALY, DYSTONIA, DYSERYTHROPOIETI...\n",
      "  Final Ctx [15]: Instruct patient on signs and symptoms to be reported to health care provider (e.g., chronic pain, skin breakdown, tingl...\n",
      "  Final Ctx [16]: CHILD 2-18 years: Body mass index (BMI) > 85th percentile or 25 kg/m<sup>2</sup> but < 95th percentile or 30 kg/m<sup>2<...\n",
      "  Final Ctx [17]: Síndrome caracterizado por estenosis u oclusión de múltiples arterias (incluidos vasos renales, cerebrales y abdominales...\n",
      "  Final Ctx [18]: Síndrome caracterizado por la asociación de microcefalia, bajo peso de nacimiento y déficit intelectual severo con enani...\n",
      "  Final Ctx [19]: Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal et...\n",
      "  Final Ctx [20]: Bleeding into the lateral cerebral ventricles of a newborn infant with ventricular dilatation directly attributable to t...\n",
      "  Final Ctx [21]: Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SER...\n",
      "  Final Ctx [22]: Monitor for hematological manifestations of hypophosphatemia (e.g., anemia; increased hemoglobin affinity with oxygen le...\n",
      "  Final Ctx [23]: Deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts...\n",
      "  Final Ctx [24]: HEMOGLOBIN LEVEL <11 G/DL...\n",
      "  Final Ctx [25]: Una hemoglobinopatía rara, de causa genética, caracterizada por un fenotipo clínico en general leve, niveles elevados de...\n",
      "  Final Ctx [26]: CHILD 2-18 years: Body mass index (BMI) approaching 85th percentile or 25 kg/m<sup>2</sup>...\n",
      "  Final Ctx [27]: Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c...\n",
      "  Final Ctx [28]: An autosomal recessive hemoglobinopathy with a mild clinical course. Most patients are asymptomatic. When symptoms appea...\n",
      "  Final Ctx [29]: Hemoglobin in the urine that is due to hemolysis from an external cause....\n",
      "  Final Ctx [30]: Syndrome with the association of microcephaly, low birth weight and severe intellectual deficit with dwarfism, small tee...\n",
      "  Final Ctx [31]: Provide written instructions for addressing signs and symptoms that require immediate medical attention (e.g., bright re...\n",
      "  Final Ctx [32]: Reticulocyte corpuscular hemoglobin concentration mean &#x7C; Blood &#x7C; Hematology and Cell counts...\n",
      "  Final Ctx [33]: CHILD 2-18 years: Body mass index (BMI) > 95th percentile or 30 kg/m<sup>2</sup> for age and gender...\n",
      "  Final Ctx [34]: Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes. [https://orcid.org/0000...\n",
      "  Final Ctx [35]: HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT...\n",
      "  Final Ctx [36]: Most recent hemoglobin (hgb) level > 12.0 g/dl...\n",
      "  Final Ctx [37]: Most recent hemoglobin (hgb) level < 10 g/dl...\n",
      "  Final Ctx [38]: Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom s...\n",
      "  Final Ctx [39]: Monitor for signs and symptoms of hypophosphatemia: bleeding tendencies; muscular weakness; paresthesia; hemolytic anemi...\n",
      "  Final Ctx [40]: Detección de hemoglobina en un lugar donde normalmente no debería estar presente...\n",
      "  Final Ctx [41]: Elevated bilirubin levels in the blood of a newborn infant. It is a normal response due to the limited ability to excret...\n",
      "  Final Ctx [42]: Hemoglobin (normal 12-16 gm%)...\n",
      "  Final Ctx [43]: A question about an individual watching for and reporting their child's physical symptoms and medical condition to the m...\n",
      "  Final Ctx [44]: Low blood counts, anemia, low white blood cell count, or low platelet count...\n",
      "--------------------------------------------------\n",
      "\n",
      "--- STAGE 4: LLM Generation ---\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-08-04 04:45:48,202 - INFO - HTTP Request: POST https://ollama.zib.de/api/chat/completions \"HTTP/1.1 200 OK\"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- FINAL LLM OUTPUT ---\n",
      "{\n",
      "  \"is_answer_correct\": \"yes\",\n",
      "  \"cop_index\": \"2\",\n",
      "  \"answer\": \"Maturation of erythroid progenitor cells\",\n",
      "  \"why_correct\": \"The patient's symptoms such as worsening fatigue, frequent upper respiratory tract infections, pallor, diffuse hyperpigmented macules, absence of the radial bones, and hypoplastic thumbs are indicative of a condition affecting the blood cells. The patient's low hemoglobin concentration, leukocyte count, and platelet count further support this. In particular, the mention of erythroid progenitor cells in the context of genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia) indicates that the condition is likely related to the maturation of erythroid progenitor cells. Furthermore, the description of the patient's symptoms as consistent with Diamond-Blackfan anemia, a rare disorder characterized by ineffective hematopoiesis and a defect in the production of red blood cells, supports this answer.\",\n",
      "  \"why_others_incorrect\": \"Option 0 is incorrect because glucocerebroside hydrolysis is not directly related to the patient's symptoms. Option 1 is incorrect because DNA interstrand crosslink repair is also not relevant to the patient's condition. Option 3 is incorrect because Ras signal transduction pathway is not involved in the maturation of erythroid progenitor cells.\"\n",
      "}\n",
      "\n",
      "--- ANALYSIS ---\n",
      "Correct Index:    1\n",
      "Predicted Index:  2\n",
      "❌ RESULT: INCORRECT\n",
      "--------------------\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# --- STAGE 2: GRAPH TRAVERSAL ---\n",
    "print(\"--- STAGE 2: Knowledge Graph Traversal ---\")\n",
    "retrieved_definitions = get_definitions_from_graph(nebula_client, suis)\n",
    "print(f\"Retrieved {len(retrieved_definitions)} definitions from the graph.\")\n",
    "for i, definition in enumerate(retrieved_definitions[:5]): # Print first 5\n",
    "    print(f\"  Initial Def [{i}]: {definition[:120]}...\")\n",
    "print(\"--------------------------------------------------\\n\")\n",
    "\n",
    "# --- STAGE 3: RE-RANKING ---\n",
    "print(f\"--- STAGE 3: Re-ranking (Top {RERANK_TOP_K}) ---\")\n",
    "final_definitions = rerank_definitions(question, retrieved_definitions, top_k=RERANK_TOP_K)\n",
    "#combined_context = list(set(top_semantic_texts + graph_definitions))\n",
    "final_definitions = list(set(top_semantic_texts + final_definitions))\n",
    "#final_definitions = rerank_definitions(question, final_definitions, top_k=RERANK_TOP_K)\n",
    "print(f\"Selected the top {len(final_definitions)} most relevant definitions.\")\n",
    "for i, definition in enumerate(final_definitions):\n",
    "    print(f\"  Final Ctx [{i}]: {definition[:120]}...\")\n",
    "print(\"--------------------------------------------------\\n\")\n",
    "# --- STAGE 4: GENERATION ---\n",
    "print(\"--- STAGE 4: LLM Generation ---\")\n",
    "# Load the prompts and shots for this specific task\n",
    "prompt_assets = load_prompt_assets(TASK_NAME, PROMPT_ID, MAX_SHOTS, library_dir=\"prompt_library\")\n",
    "llm_output, definitions = generate_llm_response(llm_client, MODEL_NAME_TO_DEBUG, question, options, final_definitions, prompt_assets)\n",
    "\n",
    "print(\"\\n--- FINAL LLM OUTPUT ---\")\n",
    "# Pretty-print the JSON output for easy reading\n",
    "if llm_output:\n",
    "    print(json.dumps(llm_output, indent=2))\n",
    "    \n",
    "    # --- AUTOMATED ANALYSIS ---\n",
    "    predicted_index = llm_output.get('cop_index')\n",
    "    print(\"\\n--- ANALYSIS ---\")\n",
    "    print(f\"Correct Index:    {correct_index}\")\n",
    "    print(f\"Predicted Index:  {predicted_index}\")\n",
    "    if str(predicted_index) == str(correct_index):\n",
    "        print(\"✅ RESULT: CORRECT\")\n",
    "    else:\n",
    "        print(\"❌ RESULT: INCORRECT\")\n",
    "else:\n",
    "    print(\"LLM failed to generate a valid response.\")\n",
    "\n",
    "print(\"--------------------\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ab061edc",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7c2540df",
   "metadata": {},
   "outputs": [],
   "source": [
    "# # --- FINAL LLM OUTPUT ---\n",
    "# {\n",
    "#   \"is_answer_correct\": \"no\",\n",
    "#   \"cop_index\": \"1\",\n",
    "#   \"correct answer\": \"150-160/90-95 mmHg\",\n",
    "#   \"reasoning_steps\": [\n",
    "#     \"The context mentions patients with prehypertensive classification and comorbid conditions (e.g., heart failure, diabetes, kidney disease) to seek appropriate drug therapy if a trial of lifestyle modification fails to reduce BP to 130/80 mm Hg or less.\",\n",
    "#     \"The blood pressure goal mentioned in the context is 130/80 mmHg or less for patients with prehypertensive classification and comorbid conditions.\",\n",
    "#     \"However, the patient's pre-treatment blood pressure was 170/100 mmHg, which indicates that the patient has hypertension stage 2 (BP >= 140/90).\",\n",
    "#     \"According to the context, patients with hypertension stage 2 should aim for BP goals of 150-160/90-95 mmHg.\"\n",
    "#   ],\n",
    "#   \"why_correct\": \"The correct answer is 150-160/90-95 mmHg because it corresponds to the BP goal mentioned in the context for patients with hypertension stage 2.\",\n",
    "#   \"why_others_incorrect\": \"Options 0, 2, and 3 are incorrect because they do not correspond to the BP goal mentioned in the context for patients with hypertension stage 2.\"\n",
    "# }\n",
    "\n",
    "# --- ANALYSIS ---\n",
    "# Correct Index:    0\n",
    "# Predicted Index:  1\n",
    "# ❌ RESULT: INCORRECT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "6822dc8e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['HEMOGLOBIN LEVEL 11 G/DL-12.9 G/DL',\n",
       " 'Hemoglobin A2+C+E+O/Hemoglobin.total &#x7C; Blood &#x7C; Hematology and Cell counts',\n",
       " 'G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis',\n",
       " 'Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)',\n",
       " 'Mental retardation, unusual facies, short stature, hyperextensibility of the joints, clinodactyly of the fifth fingers, and other defects.',\n",
       " '8-75 ENDOCRINE, METABOLIC AND HEMATOLOGIC DISORDERS SPECIFIC TO THE FETUS OR NEWBORN',\n",
       " 'An association of hypoplastic corpus callosum, mental retardation, adducted thumbs, spastic paraparesis, and hydrocephalus.',\n",
       " 'Review maternal and infant history for risk factors for hyperbilirubinemia (e.g., Rh or ABO incompatibility, polycythemia, sepsis, prematurity, malpresentation)',\n",
       " 'A sporadic syndrome of brachydactyly, thin habitus with narrow shoulders, mesomelic shortness of the arms, long lower face with obtuse mandibular angle, maxillary hypoplasia, mitral valve prolapse, and developmental delay.',\n",
       " 'I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D:Find:7D:^Patient:Ord:FACIT',\n",
       " 'G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)',\n",
       " 'Teach patient to monitor self for signs and symptoms that indicate need for medical treatment (e.g., fever, bleeding, respiratory distress, irregular pulse, cloudy outflow, and abdominal pain)',\n",
       " 'Leukomelanoderma, Infantilism, Mental Retardation, Hypodontia, Hypotrichosis',\n",
       " 'Síndrome caracterizado por anemia hemolítica no esferocítica debida a deficiencia de trifosfatasa de adenosina (ATPasa). Se describió en dos familias en las cuales estaban afectadas al menos dos generaciones. El síndrome probablemente se transmite como rasgo dominante.',\n",
       " 'CEREBELLAR HYPOPLASIA, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, CONGENITAL MICROCEPHALY, DYSTONIA, DYSERYTHROPOIETIC ANEMIA, AND GROWTH RETARDATION',\n",
       " 'Instruct patient on signs and symptoms to be reported to health care provider (e.g., chronic pain, skin breakdown, tingling, absent peripheral pulse, cool skin temperature, and changes in functional needs or goals)',\n",
       " 'CHILD 2-18 years: Body mass index (BMI) > 85th percentile or 25 kg/m<sup>2</sup> but < 95th percentile or 30 kg/m<sup>2</sup> for age and gender',\n",
       " 'Síndrome caracterizado por estenosis u oclusión de múltiples arterias (incluidos vasos renales, cerebrales y abdominales), hipertensión, braquisindactilia, sindactilia, aumento de la fragilidad ósea y dificultades de aprendizaje o déficit intelectual limítrofe. Hasta la fecha, el síndrome ha sido informado en seis pacientes de tres familias. En algunos casos también se informaron defectos cardíacos. Aún no se ha identificado con certeza el modo de transmisión y se propusieron una herencia autosómica dominante con penetración disminuida y mosaicismo gonadal parental.',\n",
       " 'Síndrome caracterizado por la asociación de microcefalia, bajo peso de nacimiento y déficit intelectual severo con enanismo, dientes pequeños y diabetes mellitus. Se describieron dos casos. Las pruebas bioquímicas revelan la presencia de niveles elevados de alanina en la orina y niveles elevados de alanina, piruvato y lactato en la sangre.',\n",
       " 'Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)',\n",
       " 'Bleeding into the lateral cerebral ventricles of a newborn infant with ventricular dilatation directly attributable to the acute bleeding.',\n",
       " 'Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid',\n",
       " 'Monitor for hematological manifestations of hypophosphatemia (e.g., anemia; increased hemoglobin affinity with oxygen leading to increased SaO2; increased risk of infection resulting from impaired WBC functioning; thrombocytopenia; bruising and hemorrhage resulting from platelet dysfunction)',\n",
       " 'Deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts',\n",
       " 'HEMOGLOBIN LEVEL <11 G/DL',\n",
       " 'Una hemoglobinopatía rara, de causa genética, caracterizada por un fenotipo clínico en general leve, niveles elevados de hemoglobina fetal y microcitosis e hipocromía leves. En algunos casos se informaron manifestaciones de drepanocitosis aguda, es decir síndrome torácico agudo y crisis dolorosa aguda.',\n",
       " 'CHILD 2-18 years: Body mass index (BMI) approaching 85th percentile or 25 kg/m<sup>2</sup>',\n",
       " 'Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period',\n",
       " 'An autosomal recessive hemoglobinopathy with a mild clinical course. Most patients are asymptomatic. When symptoms appear, they include mild hemolytic anemia and occasionally jaundice.',\n",
       " 'Hemoglobin in the urine that is due to hemolysis from an external cause.',\n",
       " 'Syndrome with the association of microcephaly, low birth weight and severe intellectual deficit with dwarfism, small teeth and diabetes mellitus. Two cases have been described. Biochemical tests reveal the presence of high levels of alanine in the urine and elevated alanine, pyruvate and lactate levels in the blood.',\n",
       " 'Provide written instructions for addressing signs and symptoms that require immediate medical attention (e.g., bright red vaginal bleeding, leaking of amniotic fluid, unusual vaginal discharge, decreased fetal movement, four or more contractions per hour before 37 weeks of gestation, headache, visual disturbances, epigastric pain, rapid weight gain with facial edema)',\n",
       " 'Reticulocyte corpuscular hemoglobin concentration mean &#x7C; Blood &#x7C; Hematology and Cell counts',\n",
       " 'CHILD 2-18 years: Body mass index (BMI) > 95th percentile or 30 kg/m<sup>2</sup> for age and gender',\n",
       " 'Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes. [https://orcid.org/0000-0002-0736-9199]',\n",
       " 'HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT',\n",
       " 'Most recent hemoglobin (hgb) level > 12.0 g/dl',\n",
       " 'Most recent hemoglobin (hgb) level < 10 g/dl',\n",
       " 'Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)',\n",
       " 'Monitor for signs and symptoms of hypophosphatemia: bleeding tendencies; muscular weakness; paresthesia; hemolytic anemia; depressed white cell function; nausea; vomiting; anorexia; and bone demineralization',\n",
       " 'Detección de hemoglobina en un lugar donde normalmente no debería estar presente',\n",
       " 'Elevated bilirubin levels in the blood of a newborn infant. It is a normal response due to the limited ability to excrete bilirubin until the maturation of the neonatal liver is complete.',\n",
       " 'Hemoglobin (normal 12-16 gm%)',\n",
       " \"A question about an individual watching for and reporting their child's physical symptoms and medical condition to the medical team.\",\n",
       " 'Low blood counts, anemia, low white blood cell count, or low platelet count']"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#imp sui S18141242\n",
    "definitions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "919320d1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading Bio-Specific Cross-Encoder model 'bionlp/bluebert_pubmed_uncased_L-24_H-1024_A-16'...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of BertForSequenceClassification were not initialized from the model checkpoint at bionlp/bluebert_pubmed_uncased_L-24_H-1024_A-16 and are newly initialized: ['classifier.bias', 'classifier.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n",
      "2025-08-04 05:48:50,541 - INFO - Use pytorch device: cuda:0\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model loaded successfully.\n"
     ]
    }
   ],
   "source": [
    "# Cell 2: Load a Pre-trained Model and Tokenizer\n",
    "# We'll use a BERT model because its attention is very easy to interpret for this task.\n",
    "# While not the exact LLM you're using, the principles of attention are the same.\n",
    "\n",
    "# model_name = 'bert-base-uncased'\n",
    "# tokenizer = BertTokenizer.from_pretrained(model_name)\n",
    "# model = BertModel.from_pretrained(model_name, output_attentions=True)\n",
    "\n",
    "# print(f\"Loaded '{model_name}' for analysis.\")\n",
    "\n",
    "\n",
    "#model_name = \"pritamdeka/S-PubMedBert-MS-MARCO\"\n",
    "model_name = \"bionlp/bluebert_pubmed_uncased_L-24_H-1024_A-16\"\n",
    "\n",
    "print(f\"Loading Bio-Specific Cross-Encoder model '{model_name}'...\")\n",
    "cross_encoder = CrossEncoder(model_name)\n",
    "print(\"Model loaded successfully.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d8245b2c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# q=\"Which of the following structural elements is characteristic of the ortopramide group drugs?\"\n",
    "# d=[\"The 'ortopramides,' also known as substituted benzamides, represent a significant class of dopamine D2 receptor antagonists. Structurally, the defining characteristic of this group is a benzamide core with a methoxy group positioned at the ortho- (2-) position of the aromatic ring. This specific arrangement is crucial for their pharmacological activity. While some related compounds like phenothiazines are also used as antiemetics, they lack this precise benzamide structure.\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "3dd0a89d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def softmax(x):\n",
    "    \"\"\"Compute softmax values for a set of scores x.\"\"\"\n",
    "    e_x = np.exp(x - np.max(x)) # Subtract max for numerical stability\n",
    "    return e_x / e_x.sum(axis=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "96bf9d29",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Scoring relevance of each definition against the question... ---\n",
      "\n",
      "\n",
      "========================================================================\n",
      "  DEFINITIVE RELEVANCE RANKING REPORT\n",
      "========================================================================\n",
      "This table shows which of your retrieved definitions is most relevant to the question.\n",
      "A high positive score is good. A low or negative score is bad.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Relevance_Score (Logit)</th>\n",
       "      <th>Probability (%)</th>\n",
       "      <th>Definition</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.563283</td>\n",
       "      <td>2.46%</td>\n",
       "      <td>Deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.560051</td>\n",
       "      <td>2.45%</td>\n",
       "      <td>Hemoglobin (normal 12-16 gm%)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.558934</td>\n",
       "      <td>2.45%</td>\n",
       "      <td>Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.557852</td>\n",
       "      <td>2.45%</td>\n",
       "      <td>Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.553949</td>\n",
       "      <td>2.44%</td>\n",
       "      <td>An association of hypoplastic corpus callosum, mental retardation, adducted thumbs, spastic paraparesis, and hydrocephalus.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.550962</td>\n",
       "      <td>2.43%</td>\n",
       "      <td>Review maternal and infant history for risk factors for hyperbilirubinemia (e.g., Rh or ABO incompatibility, polycythemia, sepsis, prematurity, malpresentation)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>0.545968</td>\n",
       "      <td>2.42%</td>\n",
       "      <td>Reticulocyte corpuscular hemoglobin concentration mean &amp;#x7C; Blood &amp;#x7C; Hematology and Cell counts</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>0.545847</td>\n",
       "      <td>2.42%</td>\n",
       "      <td>Hemoglobin A2+C+E+O/Hemoglobin.total &amp;#x7C; Blood &amp;#x7C; Hematology and Cell counts</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>0.543151</td>\n",
       "      <td>2.41%</td>\n",
       "      <td>CHILD 2-18 years: Body mass index (BMI) &gt; 85th percentile or 25 kg/m&lt;sup&gt;2&lt;/sup&gt; but &lt; 95th percentile or 30 kg/m&lt;sup&gt;2&lt;/sup&gt; for age and gender</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>0.542095</td>\n",
       "      <td>2.41%</td>\n",
       "      <td>G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>0.540652</td>\n",
       "      <td>2.40%</td>\n",
       "      <td>Leukomelanoderma, Infantilism, Mental Retardation, Hypodontia, Hypotrichosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>0.527261</td>\n",
       "      <td>2.37%</td>\n",
       "      <td>Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes. [https://orcid.org/0000-0002-0736-9199]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>0.525571</td>\n",
       "      <td>2.37%</td>\n",
       "      <td>G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>0.521403</td>\n",
       "      <td>2.36%</td>\n",
       "      <td>Teach patient to monitor self for signs and symptoms that indicate need for medical treatment (e.g., fever, bleeding, respiratory distress, irregular pulse, cloudy outflow, and abdominal pain)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>0.516194</td>\n",
       "      <td>2.35%</td>\n",
       "      <td>An autosomal recessive hemoglobinopathy with a mild clinical course. Most patients are asymptomatic. When symptoms appear, they include mild hemolytic anemia and occasionally jaundice.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>0.509039</td>\n",
       "      <td>2.33%</td>\n",
       "      <td>Most recent hemoglobin (hgb) level &gt; 12.0 g/dl</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>0.508878</td>\n",
       "      <td>2.33%</td>\n",
       "      <td>8-75 ENDOCRINE, METABOLIC AND HEMATOLOGIC DISORDERS SPECIFIC TO THE FETUS OR NEWBORN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>0.506622</td>\n",
       "      <td>2.32%</td>\n",
       "      <td>Monitor for signs and symptoms of hypophosphatemia: bleeding tendencies; muscular weakness; paresthesia; hemolytic anemia; depressed white cell function; nausea; vomiting; anorexia; and bone demineralization</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>0.505201</td>\n",
       "      <td>2.32%</td>\n",
       "      <td>Documentation of medical reason(s) for patient having a hemoglobin level &lt; 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>0.505172</td>\n",
       "      <td>2.32%</td>\n",
       "      <td>Most recent hemoglobin (hgb) level &lt; 10 g/dl</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>0.499479</td>\n",
       "      <td>2.31%</td>\n",
       "      <td>CEREBELLAR HYPOPLASIA, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, CONGENITAL MICROCEPHALY, DYSTONIA, DYSERYTHROPOIETIC ANEMIA, AND GROWTH RETARDATION</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>0.481315</td>\n",
       "      <td>2.27%</td>\n",
       "      <td>Syndrome with the association of microcephaly, low birth weight and severe intellectual deficit with dwarfism, small teeth and diabetes mellitus. Two cases have been described. Biochemical tests reveal the presence of high levels of alanine in the urine and elevated alanine, pyruvate and lactate levels in the blood.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>0.477743</td>\n",
       "      <td>2.26%</td>\n",
       "      <td>Bleeding into the lateral cerebral ventricles of a newborn infant with ventricular dilatation directly attributable to the acute bleeding.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>0.464849</td>\n",
       "      <td>2.23%</td>\n",
       "      <td>CHILD 2-18 years: Body mass index (BMI) &gt; 95th percentile or 30 kg/m&lt;sup&gt;2&lt;/sup&gt; for age and gender</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>0.462389</td>\n",
       "      <td>2.22%</td>\n",
       "      <td>Mental retardation, unusual facies, short stature, hyperextensibility of the joints, clinodactyly of the fifth fingers, and other defects.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>0.455440</td>\n",
       "      <td>2.21%</td>\n",
       "      <td>Hemoglobin in the urine that is due to hemolysis from an external cause.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>0.455216</td>\n",
       "      <td>2.21%</td>\n",
       "      <td>Monitor for hematological manifestations of hypophosphatemia (e.g., anemia; increased hemoglobin affinity with oxygen leading to increased SaO2; increased risk of infection resulting from impaired WBC functioning; thrombocytopenia; bruising and hemorrhage resulting from platelet dysfunction)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>0.451166</td>\n",
       "      <td>2.20%</td>\n",
       "      <td>HEMOGLOBIN LEVEL 11 G/DL-12.9 G/DL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>0.449808</td>\n",
       "      <td>2.20%</td>\n",
       "      <td>Elevated bilirubin levels in the blood of a newborn infant. It is a normal response due to the limited ability to excrete bilirubin until the maturation of the neonatal liver is complete.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>0.449087</td>\n",
       "      <td>2.19%</td>\n",
       "      <td>Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>0.448254</td>\n",
       "      <td>2.19%</td>\n",
       "      <td>A question about an individual watching for and reporting their child's physical symptoms and medical condition to the medical team.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>0.445565</td>\n",
       "      <td>2.19%</td>\n",
       "      <td>Low blood counts, anemia, low white blood cell count, or low platelet count</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>0.445472</td>\n",
       "      <td>2.19%</td>\n",
       "      <td>HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>0.442175</td>\n",
       "      <td>2.18%</td>\n",
       "      <td>HEMOGLOBIN LEVEL &lt;11 G/DL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>0.441872</td>\n",
       "      <td>2.18%</td>\n",
       "      <td>A sporadic syndrome of brachydactyly, thin habitus with narrow shoulders, mesomelic shortness of the arms, long lower face with obtuse mandibular angle, maxillary hypoplasia, mitral valve prolapse, and developmental delay.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>0.367916</td>\n",
       "      <td>2.02%</td>\n",
       "      <td>Detección de hemoglobina en un lugar donde normalmente no debería estar presente</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>0.333211</td>\n",
       "      <td>1.95%</td>\n",
       "      <td>Instruct patient on signs and symptoms to be reported to health care provider (e.g., chronic pain, skin breakdown, tingling, absent peripheral pulse, cool skin temperature, and changes in functional needs or goals)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>0.303096</td>\n",
       "      <td>1.90%</td>\n",
       "      <td>Síndrome caracterizado por estenosis u oclusión de múltiples arterias (incluidos vasos renales, cerebrales y abdominales), hipertensión, braquisindactilia, sindactilia, aumento de la fragilidad ósea y dificultades de aprendizaje o déficit intelectual limítrofe. Hasta la fecha, el síndrome ha sido informado en seis pacientes de tres familias. En algunos casos también se informaron defectos cardíacos. Aún no se ha identificado con certeza el modo de transmisión y se propusieron una herencia autosómica dominante con penetración disminuida y mosaicismo gonadal parental.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>0.302253</td>\n",
       "      <td>1.89%</td>\n",
       "      <td>Una hemoglobinopatía rara, de causa genética, caracterizada por un fenotipo clínico en general leve, niveles elevados de hemoglobina fetal y microcitosis e hipocromía leves. En algunos casos se informaron manifestaciones de drepanocitosis aguda, es decir síndrome torácico agudo y crisis dolorosa aguda.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>0.300132</td>\n",
       "      <td>1.89%</td>\n",
       "      <td>Síndrome caracterizado por anemia hemolítica no esferocítica debida a deficiencia de trifosfatasa de adenosina (ATPasa). Se describió en dos familias en las cuales estaban afectadas al menos dos generaciones. El síndrome probablemente se transmite como rasgo dominante.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>0.294144</td>\n",
       "      <td>1.88%</td>\n",
       "      <td>Provide written instructions for addressing signs and symptoms that require immediate medical attention (e.g., bright red vaginal bleeding, leaking of amniotic fluid, unusual vaginal discharge, decreased fetal movement, four or more contractions per hour before 37 weeks of gestation, headache, visual disturbances, epigastric pain, rapid weight gain with facial edema)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>0.289518</td>\n",
       "      <td>1.87%</td>\n",
       "      <td>Síndrome caracterizado por la asociación de microcefalia, bajo peso de nacimiento y déficit intelectual severo con enanismo, dientes pequeños y diabetes mellitus. Se describieron dos casos. Las pruebas bioquímicas revelan la presencia de niveles elevados de alanina en la orina y niveles elevados de alanina, piruvato y lactato en la sangre.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>0.289311</td>\n",
       "      <td>1.87%</td>\n",
       "      <td>I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D:Find:7D:^Patient:Ord:FACIT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>0.284334</td>\n",
       "      <td>1.86%</td>\n",
       "      <td>Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>0.283187</td>\n",
       "      <td>1.86%</td>\n",
       "      <td>CHILD 2-18 years: Body mass index (BMI) approaching 85th percentile or 25 kg/m&lt;sup&gt;2&lt;/sup&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Relevance_Score (Logit) Probability (%)  \\\n",
       "0                  0.563283           2.46%   \n",
       "1                  0.560051           2.45%   \n",
       "2                  0.558934           2.45%   \n",
       "3                  0.557852           2.45%   \n",
       "4                  0.553949           2.44%   \n",
       "5                  0.550962           2.43%   \n",
       "6                  0.545968           2.42%   \n",
       "7                  0.545847           2.42%   \n",
       "8                  0.543151           2.41%   \n",
       "9                  0.542095           2.41%   \n",
       "10                 0.540652           2.40%   \n",
       "11                 0.527261           2.37%   \n",
       "12                 0.525571           2.37%   \n",
       "13                 0.521403           2.36%   \n",
       "14                 0.516194           2.35%   \n",
       "15                 0.509039           2.33%   \n",
       "16                 0.508878           2.33%   \n",
       "17                 0.506622           2.32%   \n",
       "18                 0.505201           2.32%   \n",
       "19                 0.505172           2.32%   \n",
       "20                 0.499479           2.31%   \n",
       "21                 0.481315           2.27%   \n",
       "22                 0.477743           2.26%   \n",
       "23                 0.464849           2.23%   \n",
       "24                 0.462389           2.22%   \n",
       "25                 0.455440           2.21%   \n",
       "26                 0.455216           2.21%   \n",
       "27                 0.451166           2.20%   \n",
       "28                 0.449808           2.20%   \n",
       "29                 0.449087           2.19%   \n",
       "30                 0.448254           2.19%   \n",
       "31                 0.445565           2.19%   \n",
       "32                 0.445472           2.19%   \n",
       "33                 0.442175           2.18%   \n",
       "34                 0.441872           2.18%   \n",
       "35                 0.367916           2.02%   \n",
       "36                 0.333211           1.95%   \n",
       "37                 0.303096           1.90%   \n",
       "38                 0.302253           1.89%   \n",
       "39                 0.300132           1.89%   \n",
       "40                 0.294144           1.88%   \n",
       "41                 0.289518           1.87%   \n",
       "42                 0.289311           1.87%   \n",
       "43                 0.284334           1.86%   \n",
       "44                 0.283187           1.86%   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Definition  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Hemoglobin (normal 12-16 gm%)  \n",
       "2                                                                                                                                                                                                                                                                                                                             Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid  \n",
       "3                                                                                Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)  \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                    An association of hypoplastic corpus callosum, mental retardation, adducted thumbs, spastic paraparesis, and hydrocephalus.  \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                               Review maternal and infant history for risk factors for hyperbilirubinemia (e.g., Rh or ABO incompatibility, polycythemia, sepsis, prematurity, malpresentation)  \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Reticulocyte corpuscular hemoglobin concentration mean &#x7C; Blood &#x7C; Hematology and Cell counts  \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Hemoglobin A2+C+E+O/Hemoglobin.total &#x7C; Blood &#x7C; Hematology and Cell counts  \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                               CHILD 2-18 years: Body mass index (BMI) > 85th percentile or 25 kg/m<sup>2</sup> but < 95th percentile or 30 kg/m<sup>2</sup> for age and gender  \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                                                                        G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)  \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Leukomelanoderma, Infantilism, Mental Retardation, Hypodontia, Hypotrichosis  \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                                                      Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes. [https://orcid.org/0000-0002-0736-9199]  \n",
       "12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis  \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                              Teach patient to monitor self for signs and symptoms that indicate need for medical treatment (e.g., fever, bleeding, respiratory distress, irregular pulse, cloudy outflow, and abdominal pain)  \n",
       "14                                                                                                                                                                                                                                                                                                                                                                                                      An autosomal recessive hemoglobinopathy with a mild clinical course. Most patients are asymptomatic. When symptoms appear, they include mild hemolytic anemia and occasionally jaundice.  \n",
       "15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Most recent hemoglobin (hgb) level > 12.0 g/dl  \n",
       "16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          8-75 ENDOCRINE, METABOLIC AND HEMATOLOGIC DISORDERS SPECIFIC TO THE FETUS OR NEWBORN  \n",
       "17                                                                                                                                                                                                                                                                                                                                                                               Monitor for signs and symptoms of hypophosphatemia: bleeding tendencies; muscular weakness; paresthesia; hemolytic anemia; depressed white cell function; nausea; vomiting; anorexia; and bone demineralization  \n",
       "18                                                                                                                                                                                         Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)  \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Most recent hemoglobin (hgb) level < 10 g/dl  \n",
       "20                                                                                                                                                                                                                                                                                                                                                                                                                                      CEREBELLAR HYPOPLASIA, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, CONGENITAL MICROCEPHALY, DYSTONIA, DYSERYTHROPOIETIC ANEMIA, AND GROWTH RETARDATION  \n",
       "21                                                                                                                                                                                                                                                                 Syndrome with the association of microcephaly, low birth weight and severe intellectual deficit with dwarfism, small teeth and diabetes mellitus. Two cases have been described. Biochemical tests reveal the presence of high levels of alanine in the urine and elevated alanine, pyruvate and lactate levels in the blood.  \n",
       "22                                                                                                                                                                                                                                                                                                                                                                                                                                                    Bleeding into the lateral cerebral ventricles of a newborn infant with ventricular dilatation directly attributable to the acute bleeding.  \n",
       "23                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           CHILD 2-18 years: Body mass index (BMI) > 95th percentile or 30 kg/m<sup>2</sup> for age and gender  \n",
       "24                                                                                                                                                                                                                                                                                                                                                                                                                                                    Mental retardation, unusual facies, short stature, hyperextensibility of the joints, clinodactyly of the fifth fingers, and other defects.  \n",
       "25                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Hemoglobin in the urine that is due to hemolysis from an external cause.  \n",
       "26                                                                                                                                                                                                                                                                                          Monitor for hematological manifestations of hypophosphatemia (e.g., anemia; increased hemoglobin affinity with oxygen leading to increased SaO2; increased risk of infection resulting from impaired WBC functioning; thrombocytopenia; bruising and hemorrhage resulting from platelet dysfunction)  \n",
       "27                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            HEMOGLOBIN LEVEL 11 G/DL-12.9 G/DL  \n",
       "28                                                                                                                                                                                                                                                                                                                                                                                                   Elevated bilirubin levels in the blood of a newborn infant. It is a normal response due to the limited ability to excrete bilirubin until the maturation of the neonatal liver is complete.  \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)  \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                          A question about an individual watching for and reporting their child's physical symptoms and medical condition to the medical team.  \n",
       "31                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Low blood counts, anemia, low white blood cell count, or low platelet count  \n",
       "32                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT  \n",
       "33                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     HEMOGLOBIN LEVEL <11 G/DL  \n",
       "34                                                                                                                                                                                                                                                                                                                                                                A sporadic syndrome of brachydactyly, thin habitus with narrow shoulders, mesomelic shortness of the arms, long lower face with obtuse mandibular angle, maxillary hypoplasia, mitral valve prolapse, and developmental delay.  \n",
       "35                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Detección de hemoglobina en un lugar donde normalmente no debería estar presente  \n",
       "36                                                                                                                                                                                                                                                                                                                                                                        Instruct patient on signs and symptoms to be reported to health care provider (e.g., chronic pain, skin breakdown, tingling, absent peripheral pulse, cool skin temperature, and changes in functional needs or goals)  \n",
       "37  Síndrome caracterizado por estenosis u oclusión de múltiples arterias (incluidos vasos renales, cerebrales y abdominales), hipertensión, braquisindactilia, sindactilia, aumento de la fragilidad ósea y dificultades de aprendizaje o déficit intelectual limítrofe. Hasta la fecha, el síndrome ha sido informado en seis pacientes de tres familias. En algunos casos también se informaron defectos cardíacos. Aún no se ha identificado con certeza el modo de transmisión y se propusieron una herencia autosómica dominante con penetración disminuida y mosaicismo gonadal parental.  \n",
       "38                                                                                                                                                                                                                                                                               Una hemoglobinopatía rara, de causa genética, caracterizada por un fenotipo clínico en general leve, niveles elevados de hemoglobina fetal y microcitosis e hipocromía leves. En algunos casos se informaron manifestaciones de drepanocitosis aguda, es decir síndrome torácico agudo y crisis dolorosa aguda.  \n",
       "39                                                                                                                                                                                                                                                                                                                 Síndrome caracterizado por anemia hemolítica no esferocítica debida a deficiencia de trifosfatasa de adenosina (ATPasa). Se describió en dos familias en las cuales estaban afectadas al menos dos generaciones. El síndrome probablemente se transmite como rasgo dominante.  \n",
       "40                                                                                                                                                                                                             Provide written instructions for addressing signs and symptoms that require immediate medical attention (e.g., bright red vaginal bleeding, leaking of amniotic fluid, unusual vaginal discharge, decreased fetal movement, four or more contractions per hour before 37 weeks of gestation, headache, visual disturbances, epigastric pain, rapid weight gain with facial edema)  \n",
       "41                                                                                                                                                                                                                                         Síndrome caracterizado por la asociación de microcefalia, bajo peso de nacimiento y déficit intelectual severo con enanismo, dientes pequeños y diabetes mellitus. Se describieron dos casos. Las pruebas bioquímicas revelan la presencia de niveles elevados de alanina en la orina y niveles elevados de alanina, piruvato y lactato en la sangre.  \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                                                                                                        I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D:Find:7D:^Patient:Ord:FACIT  \n",
       "43                                                                                                                                                                                                                                                                             Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period  \n",
       "44                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    CHILD 2-18 years: Body mass index (BMI) approaching 85th percentile or 25 kg/m<sup>2</sup>  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "ename": "",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31mThe Kernel crashed while executing code in the current cell or a previous cell. \n",
      "\u001b[1;31mPlease review the code in the cell(s) to identify a possible cause of the failure. \n",
      "\u001b[1;31mClick <a href='https://aka.ms/vscodeJupyterKernelCrash'>here</a> for more info. \n",
      "\u001b[1;31mView Jupyter <a href='command:jupyter.viewOutput'>log</a> for further details."
     ]
    }
   ],
   "source": [
    "# --- 2. PREPARE THE PAIRS FOR THE CROSS-ENCODER ---\n",
    "# The Cross-Encoder needs a list of [question, context] pairs.\n",
    "pairs = []\n",
    "for definition in definitions:\n",
    "    pairs.append([question, definition])\n",
    "\n",
    "# --- 3. GET THE RELEVANCE SCORES ---\n",
    "# This is the core of the analysis. The model will output a single, meaningful\n",
    "# score for each pair, indicating how relevant the definition is to the question.\n",
    "print(\"\\n--- Scoring relevance of each definition against the question... ---\")\n",
    "# Set show_progress_bar=True to see the progress for a large number of definitions.\n",
    "scores = cross_encoder.predict(pairs, show_progress_bar=False)\n",
    "\n",
    "# --- 4. CALCULATE THE PROBABILITIES ---\n",
    "probabilities = softmax(scores)\n",
    "\n",
    "# --- 5. CREATE A CLEAN, INTERPRETABLE REPORT ---\n",
    "df_scores = pd.DataFrame({\n",
    "    'Relevance_Score (Logit)': scores,\n",
    "    'Probability (%)': [f\"{p:.2%}\" for p in probabilities], # Format as percentage\n",
    "    'Definition': definitions\n",
    "})\n",
    "\n",
    "df_scores.sort_values(by='Relevance_Score (Logit)', ascending=False, inplace=True)\n",
    "df_scores.reset_index(drop=True, inplace=True)\n",
    "print(\"\\n\\n========================================================================\")\n",
    "print(\"  DEFINITIVE RELEVANCE RANKING REPORT\")\n",
    "print(\"========================================================================\")\n",
    "print(\"This table shows which of your retrieved definitions is most relevant to the question.\")\n",
    "print(\"A high positive score is good. A low or negative score is bad.\\n\")\n",
    "\n",
    "# Set display options to show the full text of the definitions\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "\n",
    "display(df_scores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "ed3105ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Downloading NLTK stopwords corpus...\n",
      "Libraries imported and stopwords are ready.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     /home/macharya/nltk_data...\n",
      "[nltk_data]   Unzipping corpora/stopwords.zip.\n"
     ]
    }
   ],
   "source": [
    "import nltk\n",
    "import string\n",
    "try:\n",
    "    from nltk.corpus import stopwords\n",
    "    stop_words = set(stopwords.words('english'))\n",
    "except LookupError:\n",
    "    print(\"Downloading NLTK stopwords corpus...\")\n",
    "    nltk.download('stopwords')\n",
    "    from nltk.corpus import stopwords\n",
    "    stop_words = set(stopwords.words('english'))\n",
    "\n",
    "warnings.filterwarnings('ignore')\n",
    "print(\"Libraries imported and stopwords are ready.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "969050c2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "========================================================================\n",
      "  ANALYZING ATTENTION FOR DEFINITION [1 / 1]\n",
      "========================================================================\n",
      "CONTEXT: \"The 'ortopramides,' also known as substituted benzamides, represent a significant class of dopamine D2 receptor antagonists. Structurally, the defining characteristic of this group is a benzamide core with a methoxy group positioned at the ortho- (2-) position of the aromatic ring. This specific arrangement is crucial for their pharmacological activity. While some related compounds like phenothiazines are also used as antiemetics, they lack this precise benzamide structure.\"\n",
      "\n",
      "--- TOP 5 MOST MEANINGFUL ATTENDED-TO WORD PAIRS (from final layer) ---\n",
      "\n",
      "*** WARNING: LOW MEANINGFUL ATTENTION. This context may be irrelevant. ***\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>(Question_Token, Context_Token)</th>\n",
       "      <th>Attention_Score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(gene, structure)</td>\n",
       "      <td>0.000970</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(protein, compounds)</td>\n",
       "      <td>0.000815</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(hem, benz)</td>\n",
       "      <td>0.000745</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(bones, compounds)</td>\n",
       "      <td>0.000736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(protein, structure)</td>\n",
       "      <td>0.000731</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  (Question_Token, Context_Token)  Attention_Score\n",
       "0               (gene, structure)         0.000970\n",
       "1            (protein, compounds)         0.000815\n",
       "2                     (hem, benz)         0.000745\n",
       "3              (bones, compounds)         0.000736\n",
       "4            (protein, structure)         0.000731"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- END OF ANALYSIS FOR DEFINITION [1] ---\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Cell 3: The Definitive Analysis Cell with AGGRESSIVE Filtering\n",
    "# ======================================================================\n",
    "# This version is designed to completely eliminate noise and show only\n",
    "# meaningful semantic connections between non-stop words.\n",
    "\n",
    "# --- 1. PASTE YOUR DATA HERE ---\n",
    "q = \"Which of the following structural elements is characteristic of the ortopramide group drugs?\"\n",
    "\n",
    "d = [\n",
    "    \"The 'ortopramides,' also known as substituted benzamides, represent a significant class of dopamine D2 receptor antagonists. Structurally, the defining characteristic of this group is a benzamide core with a methoxy group positioned at the ortho- (2-) position of the aromatic ring. This specific arrangement is crucial for their pharmacological activity. While some related compounds like phenothiazines are also used as antiemetics, they lack this precise benzamide structure.\"\n",
    "]\n",
    "\n",
    "# --- 2. LOOP THROUGH EACH DEFINITION AND ANALYZE ---\n",
    "for i, context_sentence in enumerate(d):\n",
    "    print(f\"========================================================================\")\n",
    "    print(f\"  ANALYZING ATTENTION FOR DEFINITION [{i+1} / {len(d)}]\")\n",
    "    print(f\"========================================================================\")\n",
    "    print(f\"CONTEXT: \\\"{context_sentence}\\\"\")\n",
    "    \n",
    "    # --- Tokenization and Preparation ---\n",
    "    inputs = tokenizer.encode_plus(question, context_sentence, return_tensors='pt', add_special_tokens=True, truncation=True, max_length=512)\n",
    "    input_ids = inputs['input_ids'][0]\n",
    "    tokens = tokenizer.convert_ids_to_tokens(input_ids)\n",
    "    \n",
    "    # --- Run Model and Get Attention ---\n",
    "    with torch.no_grad():\n",
    "        outputs = model(**inputs)\n",
    "        attentions = outputs.attentions\n",
    "\n",
    "    # --- Display the Clean Matrix View ---\n",
    "    #print(f\"\\n--- ATTENTION HEATMAP [{i+1}] ---\")\n",
    "    #display(model_view(attentions, tokens))\n",
    "    \n",
    "    # --- PROGRAMMATIC ANALYSIS WITH AGGRESSIVE FILTERING ---\n",
    "    sep_index = tokens.index('[SEP]')\n",
    "    question_tokens = tokens[1:sep_index]\n",
    "    context_tokens = tokens[sep_index+1:-1]\n",
    "    \n",
    "    attentions_per_layer = torch.stack(attentions).squeeze(1).mean(dim=1)\n",
    "    final_layer_attention = attentions_per_layer[-1]\n",
    "\n",
    "    # --- THE DEFINITIVE FIX FOR THE ANALYSIS ---\n",
    "    # 1. Define what to ignore: special tokens, punctuation, AND stop words.\n",
    "    special_tokens = set(tokenizer.special_tokens_map.values())\n",
    "    punctuation = set(string.punctuation)\n",
    "    # Combine all ignored tokens into one set for efficiency\n",
    "    tokens_to_ignore = special_tokens.union(punctuation).union(stop_words)\n",
    "\n",
    "    attention_scores = []\n",
    "    for q_idx, q_token in enumerate(question_tokens, 1):\n",
    "        # 2. Ignore question tokens that are noise.\n",
    "        if q_token in tokens_to_ignore or q_token.startswith('##'):\n",
    "            continue\n",
    "            \n",
    "        for c_idx, c_token in enumerate(context_tokens, sep_index + 1):\n",
    "            # 3. Ignore context tokens that are noise.\n",
    "            if c_token in tokens_to_ignore or c_token.startswith('##'):\n",
    "                continue\n",
    "\n",
    "            # 4. Ignore \"self-attention\" (optional but good practice)\n",
    "            if q_token == c_token:\n",
    "                continue\n",
    "\n",
    "            score = final_layer_attention[q_idx, c_idx].item()\n",
    "            attention_scores.append(((q_token, c_token), score))\n",
    "\n",
    "    attention_scores.sort(key=lambda x: x[1], reverse=True)\n",
    "    \n",
    "    print(\"\\n--- TOP 5 MOST MEANINGFUL ATTENDED-TO WORD PAIRS (from final layer) ---\")\n",
    "    df = pd.DataFrame(attention_scores[:5], columns=['(Question_Token, Context_Token)', 'Attention_Score'])\n",
    "    \n",
    "    if df.empty or df['Attention_Score'].iloc[0] < 0.1:\n",
    "        print(\"\\n*** WARNING: LOW MEANINGFUL ATTENTION. This context may be irrelevant. ***\")\n",
    "\n",
    "    display(df)\n",
    "    \n",
    "    print(f\"\\n--- END OF ANALYSIS FOR DEFINITION [{i+1}] ---\\n\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "97dd4c06",
   "metadata": {},
   "outputs": [],
   "source": [
    "inputs = tokenizer.encode_plus(question, definitions, return_tensors='pt', add_special_tokens=True)\n",
    "token_type_ids = inputs['token_type_ids'] # This tells the model which part is the question and which is the context\n",
    "input_ids = inputs['input_ids']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2bde29ad",
   "metadata": {},
   "outputs": [],
   "source": [
    "# for i, context_sentence in enumerate(final_definitions):\n",
    "#     print(f\"\\n--- Analyzing Attention for Definition [{i}] ---\")\n",
    "#     print(f\"Context: {context_sentence}\")\n",
    "    \n",
    "#     # --- Tokenization and Preparation ---\n",
    "#     # This now combines the question with only ONE definition at a time.\n",
    "#     # We also add truncation as a safety measure.\n",
    "#     inputs = tokenizer.encode_plus(\n",
    "#         question, \n",
    "#         context_sentence, \n",
    "#         return_tensors='pt', \n",
    "#         add_special_tokens=True,\n",
    "#         truncation=True, # This will cut off any text that is still too long\n",
    "#         max_length=512   # The model's maximum length\n",
    "#     )\n",
    "    \n",
    "#     token_type_ids = inputs['token_type_ids']\n",
    "#     input_ids = inputs['input_ids']\n",
    "#     tokens = tokenizer.convert_ids_to_tokens(input_ids[0])\n",
    "    \n",
    "#     # --- Run the Model and Get Attention ---\n",
    "#     with torch.no_grad():\n",
    "#         outputs = model(input_ids, token_type_ids=token_type_ids)\n",
    "#         attentions = outputs.attentions\n",
    "    \n",
    "#     # --- Visualization ---\n",
    "#     # This will render a new interactive heatmap for each definition.\n",
    "#     display(head_view(attentions, tokens))```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f1248a1e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Cell 3: The Analysis Cell - Plug in Your Data Here\n",
    "# ===================================================\n",
    "# 1. Find a question and the exact context from your previous runs' logs.\n",
    "# 2. Paste them into the `question` and `context` variables below.\n",
    "# 3. Run this cell to see the attention heatmap.\n",
    "\n",
    "# --- PASTE YOUR DATA HERE ---\n",
    "question = \"Which of the following structural elements is characteristic of the ortopramide group drugs?\"\n",
    "\n",
    "# Use a small, focused piece of context from your logs for a clear visualization\n",
    "context = \"An orally bioavailable benzamide type inhibitor of histone deacetylase isoenzymes 1, 2, 3 and 10, with potential antineoplastic activity. Tucidinostat is an ortho-halogenated derivative of phenothiazine.\"\n",
    "\n",
    "# --- TOKENIZATION AND PREPARATION ---\n",
    "# This prepares the text in the special format BERT expects: [CLS] question [SEP] context [SEP]\n",
    "inputs = tokenizer.encode_plus(question, context, return_tensors='pt', add_special_tokens=True)\n",
    "token_type_ids = inputs['token_type_ids'] # This tells the model which part is the question and which is the context\n",
    "input_ids = inputs['input_ids']\n",
    "\n",
    "# --- RUN THE MODEL AND GET ATTENTION ---\n",
    "with torch.no_grad():\n",
    "    outputs = model(input_ids, token_type_ids=token_type_ids)\n",
    "    attentions = outputs.attentions # This contains the attention weights for all layers and heads\n",
    "\n",
    "# --- VISUALIZATION ---\n",
    "# Convert token IDs back to human-readable tokens\n",
    "tokens = tokenizer.convert_ids_to_tokens(input_ids[0]) \n",
    "\n",
    "# Create the visualization\n",
    "# This will render an interactive heatmap directly in your notebook.\n",
    "head_view(attentions, tokens)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medkg",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
